Literature DB >> 14609950

Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids.

Alejandra Bruna1, Marta Nicolàs, Alberto Muñoz, John M Kyriakis, Carme Caelles.   

Abstract

Inhibition of the c-Jun N-terminal kinase (JNK) pathway by glucocorticoids (GCs) results in AP-1 repression. GC antagonism of AP-1 relies mainly on the transrepression function of the GC receptor (GR) and mediates essential physiological and pharmacological actions. Here we show that GCs induce the disassembly of JNK from mitogen-activated protein kinase kinase 7 (MKK7) by promoting its association with GR. Moreover, we have characterized a hormone-regulated JNK docking site in the GR ligand-binding domain that mediates GR-JNK interaction. The binding of GR to JNK is required for inhibition of JNK activation and induction of inactive JNK nuclear transfer by GCs. The dissociation of these two hormone actions shows that JNK nuclear transfer is dispensable for the downregulation of JNK activation by GCs. Nonetheless, nuclear accumulation of inactive JNK may still be relevant for enhancing the repression of AP-1 activity by GCs. In this regard, chromatin immunoprecipitation assays show that GC-induced GR-JNK association correlates with an increase in the loading of inactive JNK on the AP-1-bound response elements of the c-jun gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609950      PMCID: PMC275446          DOI: 10.1093/emboj/cdg590

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

Review 1.  Cross-talk between glucocorticoid receptor and AP-1.

Authors:  P Herrlich
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

2.  The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases.

Authors:  C Tournier; A J Whitmarsh; J Cavanagh; T Barrett; R J Davis
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase.

Authors:  D Jacobs; D Glossip; H Xing; A J Muslin; K Kornfeld
Journal:  Genes Dev       Date:  1999-01-15       Impact factor: 11.361

4.  Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones.

Authors:  I Rogatsky; K A Zarember; K R Yamamoto
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

5.  Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor alpha in fetal rat hepatocyte primary cultures.

Authors:  J J Ventura; C Roncero; I Fabregat; M Benito
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

6.  Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter.

Authors:  P Wei; N Inamdar; W V Vedeckis
Journal:  Mol Endocrinol       Date:  1998-09

7.  Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.

Authors:  C Bonny; A Oberson; S Negri; C Sauser; D F Schorderet
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

8.  All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity.

Authors:  H Y Lee; N Sueoka; W K Hong; D J Mangelsdorf; F X Claret; J M Kurie
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 9.  Anti-inflammatory actions of glucocorticoids: molecular mechanisms.

Authors:  P J Barnes
Journal:  Clin Sci (Lond)       Date:  1998-06       Impact factor: 6.124

10.  Glucocorticoids antagonize AP-1 by inhibiting the Activation/phosphorylation of JNK without affecting its subcellular distribution.

Authors:  M V González; B Jiménez; M T Berciano; J M González-Sancho; C Caelles; M Lafarga; A Muñoz
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

View more
  37 in total

1.  Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning.

Authors:  Tessi Sherrin; Thomas Blank; Cathrin Hippel; Martin Rayner; Roger J Davis; Cedomir Todorovic
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

Review 2.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

3.  Activation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinase.

Authors:  Elizabeth A Fogarty; Christina K Matulis; W Lee Kraus
Journal:  Mol Cell Endocrinol       Date:  2011-09-22       Impact factor: 4.102

Review 4.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

Review 5.  Targeting innate immunity protein kinase signalling in inflammation.

Authors:  Matthias Gaestel; Alexey Kotlyarov; Michael Kracht
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

Review 6.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

Review 7.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Authors:  Ioanna Petta; Lien Dejager; Marlies Ballegeer; Sam Lievens; Jan Tavernier; Karolien De Bosscher; Claude Libert
Journal:  Microbiol Mol Biol Rev       Date:  2016-05-11       Impact factor: 11.056

8.  Lipid raft- and protein kinase C-mediated synergism between glucocorticoid- and gonadotropin-releasing hormone signaling results in decreased cell proliferation.

Authors:  Lancelot Wehmeyer; Andrea Du Toit; Dirk M Lang; Janet P Hapgood
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

9.  Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases.

Authors:  David T Ho; A Jane Bardwell; Seema Grewal; Corey Iverson; Lee Bardwell
Journal:  J Biol Chem       Date:  2006-03-13       Impact factor: 5.157

10.  Computational prediction and experimental verification of new MAP kinase docking sites and substrates including Gli transcription factors.

Authors:  Thomas C Whisenant; David T Ho; Ryan W Benz; Jeffrey S Rogers; Robyn M Kaake; Elizabeth A Gordon; Lan Huang; Pierre Baldi; Lee Bardwell
Journal:  PLoS Comput Biol       Date:  2010-08-26       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.